Skip to main content
. 2021 May 17;129(5):057008. doi: 10.1289/EHP8171

Table 2.

Relative differences in the plaque size in aortic arch and sinus of arsenical-treated apoE/ mice relative to their control counterparts and associated 95% confidence intervals (CIs), adjusted for sex.

Exposure groups Lesion area
Percentage of total archa Percentage of aortic sinusb Aortic sinus (mm2)c
Relative difference (95% CI) p-Value Relative difference (95% CI) p-Value Relative difference (95% CI) p-Value
NaAsO2 2.6 (0.5, 4.6) 0.01 3.4 (0.1, 6.8) 0.04 0.02 (0.02, 0.05) 0.40
MMAIII 10.4 (7.5, 13.2) <0.001 9.6 (5.1, 14.1) <0.001 0.07 (0.02, 0.12) <0.01
MMAV 7.7 (5.1, 10.3) <0.001 3.7 (0.6, 8.1) 0.09 0.01 (0.04, 0.05) 0.69
DMAV 8.4 (5.7, 11.0) <0.001 6.9 (2.2, 11.5) <0.01 0.06 (0.01, 0.10) 0.02

Note: Models were fitted using simple mixed regression models to control for the intra-litter correlation, and sex was included as a covariate. All exposure groups were compared with the unexposed (control) group for each outcome separately. The corresponding data distribution is depicted in Figures 1B and 2B,E. Number of apoE/ litters (N)=Control: 12, NaAsO2: 9, MMAIII: 4, MMAV: 5; DMAV: 5. DMAV, cacodylic acid; MMAIII, monomethylarsonous acid; MMAV, disodium methyl arsonate hexahydrate; NaAsO2, sodium arsenite.

a

Percentage of oil red O-stained area over the total arch area.

b

Percentage of oil red O-stained lesion area over the total sinus area.

c

Absolute lesion area as measured by oil red O staining.